Related Experiment Video
Updated: Mar 2, 2026

The Murine Choline-Deficient, Ethionine-Supplemented CDE Diet Model of Chronic Liver Injury
Published on: October 21, 2017
Heart Disease and the Liver: Pathologic Evaluation
Anne Knoll Koehne de Gonzalez1, Jay H Lefkowitch1
1Department of Pathology and Cell Biology, Columbia University, 630 West 168th Street, PH 15 West, Rm 1574, New York, NY 10032-3725, USA.
Insights
Acute heart failure can cause liver injury, manifesting as acute cardiogenic liver injury (ACLI) or congestive hepatopathy (CH). These conditions present distinct histological and laboratory findings, with ACLI showing necrosis and CH leading to fibrosis and cirrhosis.
Area of Science:
- Cardiology
- Hepatology
- Internal Medicine
Background:
- Liver injury is a known complication of acute and chronic heart failure.
- Understanding the distinct forms of heart failure-related liver disease is crucial for patient management.
Purpose of the Study:
- To discuss the concepts of acute cardiogenic liver injury (ACLI) and cardiac or congestive hepatopathy (CH).
- To outline their clinical manifestations, histological findings, and potential sequelae.
Main Methods:
- Review of existing literature on heart failure and liver injury.
- Analysis of histological patterns and laboratory test results associated with ACLI and CH.
Main Results:
- ACLI histologically shows centrilobular hepatocellular necrosis with elevated aminotransferases.
- CH is characterized by centrilobular hepatocyte atrophy, sinusoidal dilation, fibrosis, and a cholestatic laboratory pattern.
- Certain cardiac medications may contribute to liver fibrosis.
Conclusions:
- ACLI and CH represent distinct pathophysiological processes in heart failure-related liver injury.
- Histological and laboratory findings differentiate ACLI from CH, guiding diagnosis and prognosis.
- Further research into medication-induced liver fibrosis in cardiac patients is warranted.
Abstract:
Liver injury due to acute and chronic heart failure has long been recognized. This article discusses the concepts of acute cardiogenic liver injury (ACLI) and cardiac or congestive hepatopathy (CH) along with their clinical manifestations and sequelae. Histologically, ACLI manifests as centrilobular hepatocellular necrosis, whereas CH is associated with centrilobular hepatocyte atrophy, dilated sinusoids, and perisinusoidal fibrosis, progressing to bridging fibrosis and ultimately cirrhosis. ACLI is associated with marked increases in aminotransferase levels, whereas CH is associated with a cholestatic pattern of laboratory tests. Certain cardiac medications have also been implicated as a cause of liver fibrosis.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...

